Calcium chloride

Calcium chloride
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Calcium chloride is a mineral that is FDA approved for the treatment of hypocalcemia, lead colic, magnesium intoxication, hyperkalemia,. Common adverse reactions include tingling sensations, calcium taste, a sense of oppression or “heat wave, peripheral vasodilation, local “burning” sensation, hypotention.

• Calcium Chloride Injection, USP, 10% is indicated:

• In the treatment of hypocalcemia in conditions requiring a prompt increase in plasma calcium levels (e.g., neonatal tetany and tetany due to parathyroid deficiency, vitamin D deficiency and alkalosis) and for prevention of hypocalcemia during exchange transfusions.

• As adjunctive therapy in the management of acute symptoms in lead colic.

• In the treatment of magnesium intoxication due to overdosage of magnesium sulfate.

• In severe hyperkalemia, to combat deleterious effects on electrocardiographic (ECG) function, pending correction of the potassium level in the extracellular fluid.

• In cardiac resuscitation, particularly after open heart surgery, when epinephrine fails to improve weak or ineffective myocardial contractions.

INTRACARDIAC USE

• For cardiac resuscitation, inject into the ventricular cavity, not into the heart muscle.

• Usual Adult Dosage: 200 to 800 mg (2 to 8 mL) when injected into the ventricular cavity.

INTRAVENOUS USE

Hypocalcemic Disorders

• Usual Adult Dosage: 500 mg to 1 g (5 to 10 mL) at intervals of 1 to 3 days, depending on the response of the patient and / or results of serum calcium determinations. Repeated injections may be required because of rapid excretion of calcium.

Magnesium Intoxication

• Initial Adult Dose: 500 mg (5 mL) administered promptly and the patient observed for signs of recovery before further doses are given.

Hyperkalemic ECG Disturbances of Cardiac Function

• Dosage should be adjusted by constant monitoring of ECG changes during administration.

There is limited information regarding Off-Label Guideline-Supported Use of Calcium chloride in adult patients.

• Hypocalcemia: 200 mg to 1 g calcium chloride (2 to 10 mL of a 10% solution; 55 to 273 mg elemental calcium) IV every 1 to 3 days; max rate, 1 mL/min

INTRACARDIAC USE

• 0.2 mL/kg of body weight.

INTRAVENOUS USE

'Hypocalcemic Disorders'

• 0.2 mL /kg of body weight. Maximum 1-10 mL/day.

There is limited information regarding Off-Label Guideline-Supported Use of Calcium chloride in pediatric patients.

• Advanced cardiac life support: 20 mg/kg calcium chloride (0.2 mL/kg of 10% solution; 5.5 mg/kg elemental calcium) IV or Intraosseous; administer slowly; max dose 2 g calcium chloride (546 mg elemental calcium).

• Hypocalcemia: 2.7 to 5 mg/kg calcium chloride (0.027 to 0.05 mL/kg of a 10% solution; 0.74 to 1.37 mg/kg elemental calcium) IV every 4 to 6 hours; MAX rate, 1 mL/min.

• Calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation.

• Calcium chloride should be injected into a large vein very slowly, as it may cause peripheral vasodilatation and a cutaneous burning sensation. A moderate fall in blood pressure due to vasodilatation may attend the injection. Since calcium chloride is an acidifying salt, it is usually undesirable in the treatment of hypocalcemia of renal insufficiency.

• Rapid I.V. injection may cause the patient to complain of tingling sensations, a calcium taste, a sense of oppression or “heat wave.”

• Injections of calcium chloride are accompanied by peripheral vasodilation as well as a local “burning” sensation, and there may be a moderate fall in blood pressure.

There is limited information regarding Calcium chloride Postmarketing Experience in the drug label.

There is limited information regarding Calcium chloride Drug Interactions in the drug label.

Pregnancy Category (FDA): There is no FDA guidance on usage of Calcium chloride in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Calcium chloride in women who are pregnant.

There is no FDA guidance on use of Calcium chloride during labor and delivery.

There is no FDA guidance on the use of Calcium chloride in women who are nursing.

There is no FDA guidance on the use of Calcium chloride in pediatric settings.

There is no FDA guidance on the use of Calcium chloride in geriatric settings.

There is no FDA guidance on the use of Calcium chloride with respect to specific gender populations.

There is no FDA guidance on the use of Calcium chloride with respect to specific racial populations.

There is no FDA guidance on the use of Calcium chloride in patients with renal impairment.

There is no FDA guidance on the use of Calcium chloride in patients with hepatic impairment.

There is no FDA guidance on the use of Calcium chloride in women of reproductive potentials and males.

There is no FDA guidance one the use of Calcium chloride in patients who are immunocompromised.

Intravenous

INJECT SLOWLY

• Calcium Chloride Injection, USP, 10%, is administered only by slow intravenous injection (not to exceed 1 mL/min) and / or in cardiac resuscitation, by injection into the ventricular cavity. It must not be injected into the myocardium.

• The usual precautions for intravenous therapy should be observed. If time permits, the solution should be warmed to body temperature. The injection should be halted if the patient complains of any discomfort; it may be resumed when symptoms disappear. Following injection, the patient should remain recumbent for a short time.

There is limited information regarding Calcium chloride Monitoring in the drug label.

There is limited information regarding the compatibility of Calcium chloride and IV administrations.

There is limited information regarding Calcium chloride overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox E numberTemplate:Chembox RTECSTemplate:Chembox AppearanceTemplate:Chembox OdourTemplate:Chembox DensityTemplate:Chembox MeltingPtTemplate:Chembox BoilingPtTemplate:Chembox SolubilityInWaterTemplate:Chembox SolubilityTemplate:Chembox SolubilityTemplate:Chembox SolubilityTemplate:Chembox SolubilityTemplate:Chembox SolubilityTemplate:Chembox pKaTemplate:Chembox MagSusTemplate:Chembox RefractIndexTemplate:Chembox ViscosityTemplate:Chembox StructureTemplate:Chembox ThermochemistryTemplate:Chembox GHSPictogramsTemplate:Chembox GHSSignalWordTemplate:Chembox HPhrasesTemplate:Chembox PPhrasesTemplate:Chembox NFPATemplate:Chembox Lethal amounts (set)Template:Chembox OtherAnionsTemplate:Chembox OtherCationsTemplate:Chembox Supplement

Template:Chembox header2 | Calcium chloride
Identifiers
CAS Number	10043-52-4 N 22691-02-7 (monohydrate) N 10035-04-8 (dihydrate) N 25094-02-4 (tetrahydrate) N 7774-34-7 (hexahydrate) N
3D model (JSmol)	Interactive image
ChEBI	CHEBI:3312 N
ChEMBL	ChEMBL1200668 N
ChemSpider	23237 Y
DrugBank	DB01164 N
ECHA InfoCard	Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
PubChem CID	24854
UNII	OFM21057LP Y
InChI InChI=1S/Ca.2ClH/h;2*1H/q+2;;/p-2 N Key: UXVMQQNJUSDDNG-UHFFFAOYSA-L N InChI=1/Ca.2ClH/h;2*1H/q+2;;/p-2 Key: UXVMQQNJUSDDNG-NUQVWONBAG
SMILES [Ca+2].[Cl-].[Cl-]
Properties
Chemical formula	CaCl2
Molar mass	110.98 g·mol−1
Hazards
Related compounds
Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references

There is limited information regarding Calcium chloride Mechanism of Action in the drug label.

Calcium Chloride Injection, USP, 10%, is a sterile aqueous solution containing, in each mL, 100 mg (1.36 mEq) calcium chloride. The pH of the solution may have been adjusted with hydrochloric acid and / or calcium hydroxide, when necessary. The air above the liquid in the individual containers has been displaced by flushing with nitrogen during the filling operation. The preparation contains no antimicrobial preservatives and is intended as a single-dose vial; once the unit is assembled and used, any remaining portion of the solution must be discarded with the entire unit. Calcium Chloride, USP, contains two molecules of water of hydration and is chemically designated as CaCl2 • 2H20.

There is limited information regarding Pharmacodynamics of Calcium chloride in the drug label.

There is limited information regarding Pharmacokinetics of Calcium chloride in the drug label.

There is limited information regarding Nonclinical Toxicology of Calcium chloride in the drug label.

There is limited information regarding Clinical Studies of Calcium chloride in the drug label.

CALCIUM CHLORIDE INJECTION, USP, 10%

In unit-use packages containing a Luer-Jet™ Luer-Lock Prefilled Syringe. Stock No. 3304 NDC 76329-3304-1 10 mL Ten cartons per package.

Syringe Assembly Directions:

USE ASEPTIC TECHNIQUE

Do not assemble until ready to use.

• Store at controlled room temperature 15° to 30°C (59° to 86°F).

This image of the FDA label is provided by the National Library of Medicine.

This image of the FDA label is provided by the National Library of Medicine.

This image of the FDA label is provided by the National Library of Medicine.

There is limited information regarding Patient Counseling Information of Calcium chloride in the drug label.

Alcohol-Calcium chloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

• CALCIUM CHLORIDE®^[7]

There is limited information regarding Calcium chloride Look-Alike Drug Names in the drug label.

Drug Shortage

The contents of this FDA label are provided by the National Library of Medicine.